Introduction
Influenza virus haemagglutinin (HA) is involved in the initial stages of virus infection and represents the antigen against which the virus-neutralizing (VN) antibody response is predominantly directed (Laver & Kilbourne, 1966 ; Wiley & Skehel, 1987) . Up to five distinct antigenic sites have been described, located on the surface of the virusmembrane distal part of HA1, based on the analyses of natural variants and laboratory variants selected in the presence of MAbs Gerhard et al., 1981 ; Caton et al., 1982 ; Daniels et al., 1983) . However, observations suggest that natural antibody responses to influenza virus HA are restricted. A large proportion (20-58 %) of human sera, particularly that from children, appears to exhibit a limited antibody repertoire to influenza virus HA (Natali et al., 1981) . Antibody response is often focused on a single antigenic site. Whilst antibodies to site A can prevail in some circumstances (Lambkin et al., 1994) , site B, located on the tip of the HA molecule near the receptor-binding region, is more commonly targeted. It has been shown that antibodies against site B (designated Sa in subtype H1) are characterized by high VN potential in comparison to those directed to other antigenic sites (Gerhard et al., 1981 ; Tamura et al., 1993) . Rabbits immunized with influenza virus of subtype H7 developed serum responses which in most individuals were directed exclusively to antigenic site B (Lambkin & Dimmock, 1995) . Similarly, mice of haplotype H-2 d and H-2 k that were infected with influenza virus of subtype H3 target their neutralizing antibody response to site B (Patera et al., 1995) . The vast majority of VN MAbs derived from H-2 d mice select virus escape variants characterized by the amino acid substitution HA 198 A to E and MAbs derived from H-2 k donors select variants of either HA 198 A to E or HA 158 G to E substitution (both belonging to site B). Moreover, HA residues 63, 189, 193 and 198 are important for the CD4 + proliferative response in BALB\c (H-2 d ) mice, thereby demonstrating the extensive commonality of B and T cell repertoires for HA of subtype H3 (Barnett et al., 1989) .
Following immunization of BALB\c mice with native influenza virus A\Bangkok\1\79 (H3N2), a hybridoma producing MAb IIB4 was obtained. This MAb selected escape variants displaying one of the following substitutions in HA : 198 A to E, 199 S to P, and 201 R to G. We conclude that MAb IIB4 is directed to the immunodominant epitope on antigenic site B of HA. This biologically important epitope is discontinuous and cannot be synthesized as an oligopeptide. Therefore, we investigated its relevance as an independent entity by means of Ab2, which mimic the IIB4 epitope. Two selected Ab2 MAbs were able to (i) elicit syngeneic polyclonal anti-anti-idiotypic antibodies (Ab3) displaying VN activity in vitro and (ii) protect a high proportion of mice from lethal virus challenge as a consequence of the Ab3 response elicited in vivo. Hence, we demonstrate that active immunization with a single HA epitope in the form of its internal image can give partial protection from influenza mortality in vivo.
Methods
Viruses. Influenza viruses A\Dunedin\4\73, A\Bangkok\1\79, and A\Mississippi\1\85 (H3N2) were propagated in embryonated hen's eggs and purified from allantoic fluid (Russ et al., 1974) .
Selection of MAb-escape variants of viruses. Serial dilutions of infectious allantoic fluid (10 −$ -10 −) ) were incubated with tenfold dilutions of MAb IIB4 (10 −" -10 −# ) ascitic fluid (1 : 1 v\v) for 2 h at room temperature and inoculated into embryonated hen's eggs (200 µl). After 48 h, allantoic fluids with haemagglutination activity were tested for IIB4 binding. Samples which had lost MAb IIB4 binding were propagated, after limiting dilutions, in embryonated hen's eggs.
Influenza virus HA gene sequencing. Nucleotide sequences of HA RNA genes were determined by the dideoxynucleotide chain terminating method as described previously (Daniels et al., 1985 ; Grambas et al., 1992) . The following primers were used : ATGAAGACTATCATTG-CTTTGAGC (forward) ; ACTGATAGATGCTCTATTGGGAGA (forward) ; AATGCTTCCATTTGGAGTGATGCA (reverse) ; and GTCTA-TCATTCCCTCCCAACCATT (reverse).
Adaptation of influenza viruses to mice. Four-week-old BALB\c mice, under light ether anaesthesia, received infectious allantoic fluid intranasally. Lung cell suspensions were prepared after 48 h and cell supernatants were administered to the next group of mice as above. Adapted virus was obtained after six to eight serial passages in mice and then grown in embryonated hen's eggs. Aliquots of adapted viruses were stored at k70 mC.
Cell lines. The Sp2\0 mouse myeloma cell line, hybridomas and MDCK cells were cultured as described by Varec) kova ! et al. (1995) . The hybridoma IIB4, producing MAbs of isotype IgG2a, was prepared as described (Russ et al., 1987) following immunization of BALB\c mice with influenza virus A\Bangkok\1\79 (H3N2).
Preparation of monoclonal anti-idiotypic antibodies
Syngeneic immunization and hybridoma production. Four-week-old BALB\c mice were injected intraperitoneally five times (50 µg\50 µl)
at 22 day intervals with protein A-Sepharose-purified MAb IIB4 coupled to keyhole limpet haemocyanin (Reth et al., 1979) adjuvanted with Al-Span-Oil (Franek & Simek, 1971) . MAb IIB4 was injected intravenously (100 µg\100 µl) 4 days before fusion of spleen and Sp2\0 cells, i.e. on day 92 (Lane et al., 1986) . Positive hybridoma cells were cloned by two cycles of limiting dilution.
Screening of hybridomas producing anti-idiotypic MAbs. Competitiveinhibition radioimmunoassays (CRIA) were performed to identify hybridomas producing anti-IIB4 antibody. Purified virus A\Bangkok\1\79 was adsorbed to a solid phase (50 ng per well) and the binding of "#&I-labelled IIB4 (25 µl) measured in the presence of 25 µl hybridoma cultivation medium (Varec) kova ! et al., 1995) . Decreases in "#&I-IIB4 binding indicated the presence of anti-IIB4 antibodies in hybridoma cultivation medium.
Preparation of anti-anti-idiotypic antibodies. BALB\c mice (4 weeks old) were injected intraperitoneally with 200 µg protein ASepharose-purified Ab2 in complete Freund's adjuvant (CFA) and boosted with Ab2 (200 µg each) in incomplete Freund's adjuvant (IFA) after 2 and 5 weeks. Mice were bled and sera were used as a source of Ab3.
Antibody characterization
Sequencing of MAb variable regions. Cytoplasmic RNA was extracted and reverse transcription and PCR were performed essentially as described by Bizebard et al. (1994) . The heavy chain fragments (" 750 bp) were amplified using a mixture of 12 primers (Jones & Bendig, 1991) in combination with Cγ2 (TATGCAAGGCTTACAACCACA). Kappa light chains (" 450 bp) were amplified using a set of 13 primers each in combination with MKC (Jones & Bendig, 1991) . Products were purified on 0n8 % SeaPlaque agarose gels (FMC), resuspended in water, sequenced using AmpliTaq cycle-sequencing kits (ABI) and analysed on an ABI 373A. Resultant sequences were assembled and translated using Staden software (Gleeson & Staden, 1991) .
Antigen binding tests (RIA and ELISA). Solid-phase immunoassays were performed according to Varec) kova ! et al. (1995) . Bound antibodies were detected with either "#&I-labelled swine anti-mouse immunoglobulin (50 000 c.p.m. per 100 µl per well) or with swine anti-mouse horseradish peroxidase-conjugated immunoglobulin by measuring the enzyme activity in the presence of activated substrate [1,2-phenylenediamine dihydrochloride (1 mg\ml) with 0n03 % H # O # ] and reading the absorbance at 492 nm (Tkacova & Varec) kova! , 1996) .
CRIA. Protein A-Sepharose-purified monoclonal or polyclonal antibodies were iodinated with Na"#&I (Amersham, 1 mCi\10 µl) using chloramine T (Hunter, 1967) . Two types of CRIA were performed : (a) MAb IIB4, Ab2 or Ab3 were used to inhibit the binding of "#&I-labelled MAb IIB4 to adsorbed virus A\Bangkok\1\79 (100 ng) ; and (b) Ab2 or Ab3 were used to inhibit the binding of homologous or heterologous "#&I-labelled Ab2 to adsorbed MAb IIB4 (50 ng). Total reaction volume was 50 µl and there was approximately 2 ng per well "#&I-labelled antibody.
Affinity estimation of MAb IIB4 and anti-idiotopic MAbs. Binding data from the homologous CRIA were used to evaluate the affinity of MAbs (Rodbard & Feldman, 1975 ; Mucha, 1993 ; Varec) kova! et al., 1993) .
Radioimmunoprecipitation assay (RIPA). RIPA was performed with influenza virus A\Dunedin\4\73 metabolically labelled with [$&S]methionine (Yewdell et al., 1988 ; Varec) kova! et al., 1995) .
Haemagglutination-inhibition (HI) test. HI activity of antibodies was determined by the micromethod of Takatsy (1955) using chicken erythrocytes.
Virus microneutralization test. Influenza virus, at an m.o.i. of 10, was incubated with various concentrations of purified antibodies (IIB4 or Ab3) for 2 h at room temperature. MDCK cells cultivated on 96-well microtitre plates were infected with the virus\antibody mixtures for 1 h at room temperature. Cell monolayers were then washed with PBS and cultivation medium containing 0n2 % FCS. Infected cells were incubated for 17 h at 37 mC, washed with PBS, fixed with 0n05 % glutaraldehyde in PBS at 4 mC and permeabilized with 0n1 % Triton X-100 for 10 min. Virus replication was evaluated using "#&I-labelled MAb 107L specific for influenza A virus nucleoprotein.
Virus protection studies
Active immunization. Three doses of either Ab2 (200 µg) or purified influenza virus (not mouse-adapted, 100 µg per animal) were administered intraperitoneally to BALB\c mice (groups of 17) at 14 day intervals : prime with CFA and boosts with IFA. Two weeks after the immunization schedule, mice were challenged intranasally with a lethal dose (2iLD &! ) of mouse-adapted influenza virus. The presence of infectious virus in the lungs was detected 48 h after infection : two mice from each group were sacrificed and lung cell suspensions for each animal were made in 2 ml PBS. For each sample, five embryonated chicken eggs were inoculated with 100 µl lung suspension and incubated at 35 mC for 2 days (Andrew et al., 1987) . The presence of virus was followed by estimation of haemagglutination activity of the allantoic fluid. Survival of the remaining mice, 15 in each experimental group, was followed for a period of 15 days. Survival significance was evaluated by the Fisher Exact Test.
Passive immunization. Purified MAb IIB4 (400 µg per animal) was given intravenously to BALB\c mice. After 1 h, mice were infected with mouse-adapted influenza virus and monitored as described for active immunization.
Results

Mapping the IIB4 epitope on HA
MAb-escape variants derived from the homologous A\Bangkok\1\79 virus stock contained amino acid substitutions at either HA 198 (A to E) or HA 199 (S to P). A third substitution at HA 201 (R to G), was observed in an escape variant of A\Mississippi\1\85. HA 198A, 199S and 201R are conserved in the three parental virus strains used in this study and most strains of subtype H3. These positions are located in antigenic site B .
Anti-idiotypic antibody response in mice
Five hundred and fifty hybridoma clones resulted from a fusion of Sp2\0 myeloma cells with spleen cells from BALB\c mice immunized with the IgG2a MAb IIB4. Of these clones, 18 % produced antibodies which inhibited the binding of MAb IIB4 to A\Bangkok\1\79 virus by 30-100 %. Two clones, designated 78 and 464, the supernatants of which inhibited binding of MAb IIB4 to HA most effectively, were selected for further study. Both produced Ab2 MAbs of IgG1 isotype.
Immunochemical characterization of anti-idiotopic MAbs
In CRIA, both Ab2 MAbs 78 and 464 completely inhibited "#&I-IIB4 binding to viral HA, although a considerably larger amount of 464 was required to achieve 50 % inhibition compared to 78 (Fig. 1 a) . The binding affinities of IIB4 to 78 (4n0i10* M −" ) and to 464 (1n9i10) M −" ) were calculated on the basis of homologous competitive curves (Fig. 1 b, c ; Varec) kova ! et al., 1993) . IIB4 bound HA of homologous virus A\Bangkok\1\79 with an affinity of 5n6i10) M −" . Thus, syngeneic immunization with primary MAb IIB4 led to the production of an Ab2 (78) which bound to its idiotope with a higher affinity than IIB4 bound to HA. Similar specificity of 78 and 464 was indicated by their mutual inhibition of binding to IIB4 in heterologous CRIA, though the inhibition potential of 464 was lower compared with that of 78 ( Fig. 1 b, c) .
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Sequence analysis of MAb IIB4 and Ab2 antibodies
To evaluate the relatedness of 78 and 464, their cDNAs encoding variable regions VH and VL, together with those of MAb IIB4, were sequenced and compared and their amino acid sequences deduced (Fig. 2) . The VH and VL cDNA products were generated with specific primers for IIB4 and 464, MHV2\MKV7 and MHV1\MKV5 (Jones & Bendig, 1991) , respectively, whilst 78 yielded two products for each chain of primers MHV2\MHV7 and MKV1\MKV6. Over the FR1-FR4 regions, the pairs of VH and VL cDNAs gave identical sequences for 78.
The VH regions of Ab2 78 (accession number AF004332) and 464 (accession number AF004333) belong to different families (VII and IX, respectively) despite the relatively high nucleotide identity (76 %) between them ( Table 1 ). The VL regions of Ab2 MAbs 78 (accession number AF004329) and 464 (accession number AF004330) also derive from different families (XVI and XI, respectively) and show 66 % identity. For the complementarity-determining regions (CDR), VH and VL sequences showed lower nucleotide identity between 78 and 464 (61 % for VH and 55 % for VL) but the ratio (VH\VL) was maintained (Table 1 ). In spite of the common functionality and consequent structural similarity (internal image) of 78 and 464, no prominent cluster of amino acid identity within the CDRs was observed between them (Fig. 2) .
Higher VH similarities were observed between IIB4 and Ab2, particularly 78, than between Ab2 78 and 464 (Table 1) . Consequently, the VH of MAb IIB4 (accession number AF004331) falls into the same family (VII) as the VH of 78. Despite the overall high degree of VH identity of IIB4 and 78, a cluster of several differences between CDR3 regions is observed (Fig. 2 a) .
The VL region of MAb IIB4 (accession number AF004328 ; Fig. 2 b) is divergent from both Ab2 VL sequences and not attributable to any known family. Therefore, it probably represents a member of a new, as yet undescribed, V kappa family.
Induction and immunochemical characterization of Ab3 antibodies
On the basis of CRIA results (Fig. 1) , we propose that both Ab2 464 and 78 are of a beta type, thereby imitating the original epitope on the HA molecule. To test this, the Ab2 MAbs were used as immunogens to induce Ab3 responses in mice, which should have specificity and biological activity similar to MAb IIB4.
Syngeneic immunization with Ab2 MAbs 78 and 464 elicited Ab3 antibody responses. Individual Ab3 sera from mice (two groups of four animals each) exhibited specific binding to A\Bangkok\1\79 virus (parental immunogen of MAb IIB4) in ELISA (not shown). In further experiments, protein A-Sepharose purified immunoglobulins from pools of anti-78 or anti-464 sera were used. Specificity of Ab3 antibodies was confirmed in radioimmunoprecipitation experiments with $&S-metabolically labelled virus. Both anti-78 and EGE Anti-idiotype responses protect against influenza Anti-idiotype responses protect against influenza anti-464 antibodies precipitated HA from influenza virusinfected MDCK cell lysates, as did MAb IIB4. MAb IIB4 precipitated both uncleaved HA0 as well as HA1, the large fragment of processed HA0, while Ab3 antibodies preferentially precipitated HA1 (not shown).
Binding profiles of Ab3 antibodies and MAb IIB4 with virus strains A\Dunedin\4\73, A\Bangkok\1\79, and A\Mississippi\1\85 were compared in ELISA (Fig. 3) . Anti-78 antibody showed binding to all three strains, as did MAb IIB4 (Fig. 3 a, b) . Anti-464 antibody exhibited negligible binding to A\Mississippi\1\85 (Fig. 3 c) . The reactivity patterns of anti-78 and anti-464 suggest subtle differences in their specificities.
The ability of Ab3 to inhibit the binding of MAb IIB4 to A\Bangkok\1\79 virus as well as the binding of Ab2 MAbs to IIB4 was followed in CRIA. Under the conditions used, anti-78 competed with IIB4 for binding to influenza virus, whereas anti-464 did not (Fig. 4 a) . However, both Ab3 antibody pools lowered the binding of "#&I-labelled Ab2 (78 or 464) to IIB4 (Fig. 4 b, c) . The differences in inhibition potentials of anti-78 and anti-464 could be attributed to the different affinities of Ab3 for HA.
These observations, together with those obtained in ELISA and RIPA, prove that Ab3 sera contain populations of antibodies specific to the HA epitope recognized by MAb IIB4, as a result of an immune response induced by anti-paratope antibodies 78 and 464. 
Comparison of biological properties of MAb IIB4 and Ab3 in vitro
MAb IIB4 showed HI and VN activities against viruses it bound to in ELISA. HI and VN activities of anti-78 and anti-464 antibody populations were determined to assess whether or not the biological properties of MAb IIB4 were preserved. Three virus strains, A\Dunedin\4\73, A\Bangkok\1\79 and A\Mississippi\1\85, showing significant reactivity with MAb IIB4 were used. Whilst IIB4 gave increasing HI titres in relation to year of virus isolation (Dunedin Bangkok Mississippi) both Ab3 antibody pools gave higher HI titres with the homologous Bangkok strain than the heterologous Dunedin and Mississippi strains (Table 2) . Thus, the HI specificity patterns of both Ab3 antibody pools distinguish them from MAb IIB4.
VN activity of Ab3 and IIB4 antibodies was determined on MDCK cell monolayers using a highly sensitive micromethod. Both anti-78 and anti-464 neutralized the infectivity of viruses A\Dunedin\4\73 and A\Bangkok\1\79 (Fig. 5 a, b) . Replication of virus A\Mississippi\1\85 was neutralized by anti-78 but not by anti-464 antibodies under the experimental conditions used (Fig. 5 c) . VN activities of both Ab3 antibody pools and IIB4 correlated with their binding activity in ELISA.
Induction of protective immune responses in mice by anti-idiotopic antibodies
To ascertain if anti-anti-idiotypic responses elicited by Ab2 are qualitatively comparable to MAb IIB4 in vivo, we followed the survival of infected mice and the presence of infectious virus in mouse lungs after passive immunization (with MAb IIB4) or active immunization (with Ab2 antibodies 78 or 464). Simultaneously, we compared the protective effects following Ab2 immunization with primary responses elicited by intact virus (A\Dunedin\4\73, A\Bangkok\1\79 or A\Mississippi\1\85). Mice were challenged with lethal doses of mouse-adapted viruses A\Dunedin\4\73 or A\Mississippi\1\85. A\Bangkok\1\79 failed to adapt to mice, therefore it could not be included in the in vivo experiments. The presence of virus in lungs of two mice from each experimental group was detected at 48 h post-infection as described in Methods. The infectious virus in lungs was eliminated in mice preimmunized with the homologous virus.
EGG
In all other groups of immunized mice, the infectious virus was detected in lungs (not shown). However, as presented below (Fig. 6) immunization by Ab2 delayed death by approximately 2 days, i.e. immunization influenced the kinetics of virus replication in lungs.
Survival of mice in each group was followed for 15 days post-challenge (Fig. 6) . No mice survived in control groups which were infected following preimmunization with PBS only. MAb IIB4 protected 50 % (P l 0n001) of mice against lethal infection with A\Mississippi\1\85 and 100 % of mice infected with A\Dunedin\4\73. The latter result is contrary to binding and biological tests performed in vitro (see above). All mice survived infection when the immunizing and infecting viruses were of the same strain. Ab2 antibodies 78 and 464 induced partially protective immune responses ; with antibodies 78 and 464, survival rates of 30 % (P l 0n022) versus 15 % (P l 0n209) have been achieved after infection with A\Dunedin\4\73 and 25 % (P l 0n051) versus 37 % (P l 0n009) after infection with A\Mississippi\1\85, respectively. Hence, the significance of protection was unambiguous (P 0n05) in the group of mice immunized with Ab2 78 and challenged with Dunedin virus as well as in a group of mice immunized with Ab2 464 and challenged with Mississippi virus. These significant levels of protection indicate the immune potential of the IIB4 epitope on HA, in isolation, in the form of an internal image.
Discussion
The immunodominant HA epitope recognized by MAb IIB4 is shared by different H3 influenza virus strains and is involved in virus neutralization by antibodies. Based on our previous studies of IIB4\HA reactivity under denaturing conditions, the epitope is conformational and not expressible as an oligopeptide (Russ et al., 1987) . Therefore, we attempted to obtain the internal image of the epitope by means of monoclonal anti-idiotypic antibodies and subsequently to study their potential as inducers of biologically relevant immune responses.
The two Ab2 MAbs chosen for study have high binding affinities for the immunizing MAb IIB4. The binding affinity of Ab2 78 to IIB4 was even higher than that of IIB4 to HA, the primary antigen. Similar patterns in affinities were observed by Fields et al. (1995) , where affinity of Ab2 to Ab1 was fivefold higher than that of Ab1 to antigen. Such strong syngeneic antiidiotypic antibody responses have been induced by repeating long-term stimulation with immunogen (MAb IIB4) coupled to a carrier and administered with adjuvants. Whilst these conditions are not physiological, they do effect antibody affinity maturation (Berek et al., 1987) as supported by the high recovery of hybridoma clones (18 %) positive for the production of antibodies interfering with MAb IIB4 binding to HA.
Both Ab2 MAbs 78 and 464 were shown to be specific to the IIB4 paratope, i.e. to be of the beta type, as they were able to induce Ab3 antibodies binding to the primary antigen, viral HA (UytdeHaag et al., 1986 ; Ertl & Bona, 1988) . Purified immunoglobulins from syngeneic immune Ab3 sera exhibited HI and VN activity in vitro. The potential of anti-78 and anti-464 to inhibit virus replication in vitro correlated with their binding to A\Dunedin\4\73, A\Bangkok\1\79 and A\ Mississippi\1\85. Anti-78 Ab3 exhibited higher VN titres with all three viruses than anti-464, which might reflect the higher affinity (20 times greater) of Ab2 78 for MAb IIB4 than that of Ab2 464. It is assumed that the Ab2, which binds to the paratope of Ab1 with highest affinity, mimics most precisely the original epitope. Therefore, Ab3 antibodies elicited by Ab2 of high affinity should better reflect the properties of Ab1.
However, no significant difference for induction of protective immune responses by MAbs 78 and 464 was observed during in vivo experiments. Both induced comparable protection of mice, 25-30 % for Ab2 78 and 15-37 % for Ab2 464, depending on the virus strain used to challenge. The VN activity of Ab3 in vitro correlates with cross-reactivity of anti-464, anti-78 and IIB4 with three virus strains in ELISA and the respective affinities of Ab2 78 and 464 for IIB4, suggesting that the affinity of Ab2 for immunogen is a major determinant of Ab3 VN activity. In contrast, affinity is not the exclusive determining factor for protection in vivo. Virus neutralization in vivo, which involves co-operation with cellular immunity, is more complex than that in vitro (Misplon et al., 1989) . It has been shown that antibodies may not be of high affinity for effective in vivo protection (McLain & Dimmock, 1989 ; Salmi, 1991) .
Sequence analyses of IIB4 and Ab2 antibodies showed : (i) that, according to Kabat's database, the VL region of MAb IIB4 probably represents a member of a new V kappa family ; and (ii) exceptionally high identity between the VHs of IIB4 and Ab2, particularly 78. In the absence of detailed structure, the relative contributions of the VH and VL of Ab2 78 to the binding of MAb IIB4 cannot be assessed. However, the CDR3 region of VH with VL, which shows low amino acid identity when comparing Ab2 78 and IIB4, is likely to be involved in mimicking the IIB4 epitope on HA.
Results presented here show that Ab2 antibodies, bearing the internal image of an immunodominant influenza virus HA epitope, can induce Ab1-like responses with HI, VN and infection-protective activities. This suggests that our Ab2 simulated the entire IIB4 epitope of HA, both immunochemically and functionally, and confirms the biological significance of the immunodominant epitope.
Protective polyclonal anti-idiotypic immunization in vivo has been described for virus models of hepatitis B virus (Kennedy et al., 1986) , pseudorabies virus (Gurish et al., 1988 ; Tsuda et al., 1992) , foot-and-mouth disease virus (Garmendia et al., 1989) , murine coronavirus (Lamarre et al., 1991) and Marek's disease virus (Dandapat et al., 1994) . Protection in vivo EGH T. Beta! kova! and others T. Beta! kova! and others against Moloney murine sarcoma virus (Powell et al., 1989) , mouse mammary tumour virus (Raychaudhuri et al., 1990) , and Semliki Forest virus (Oosterlaken et al., 1991) has been achieved using monoclonal anti-idiotypic antibodies. With the influenza virus model, Bona & Schulman (1990) did not obtain an Ab3 response displaying HI activity after syngeneic monoclonal Ab2 immunization and only a marginal priming effect of Ab2 was observed. Anders et al. (1989) described production of HA-specific Ab3 displaying HI and VN activity in vitro after immunization with polyclonal rabbit anti-idiotypic antibodies. The protective effect of Ab2 in vivo for influenza virus has not been demonstrated previously. We show, for the first time, that active immunization with a monoclonal Ab2 bearing an internal image of a single influenza virus HA epitope can lead to protection in vivo. This indicates the significance of the IIB4 epitope.
Structural domains of influenza virus antigens shared by different strains which are able to induce a protective immune response would represent epitopes suitable for vaccination. In particular, anti-idiotypes mimicking them might be advantageous in the case of conformational epitopes. Moreover, Ab2 are known to be inducers of cross-reactive Ab3 responses as described for the influenza model (Anders et al., 1989 ; Bona & Schulman, 1990 ; Kostolansky! et al., 1994) . Humanized monoclonal Ab2 with these properties might help to overcome vaccine design\formulation difficulties arising as a result of variability between influenza strains.
